Kirill dmitriev - Latest News Update, Information, Photos & Videos on Kirill dmitriev at Lokmat Times

Russian Direct Investment Fund (RDIF) is expecting to release the results of Sputnik V and Astrazeneca 'mix and match' vaccine by the end of July.In a press briefing, Kirill Dmitriev, CEO, RDIF informed that high efficacy is expected from the trials."We expect to release the results of Sputnik V and Astrazeneca mix and match by the end of July. This approach has been really pioneered by Sputnik V in the beginning. So we are open for mix and match a Covishield in India. We believe there will be a great result. Covishield is the same vaccine as Astrazeneca so we believe that trials will show high efficacy. We hope that the Serum Institute of India (SII) can produce Sputnik V and mix and match as well. It will be a true partnership," said Dmitriev.RDIF, Russia's sovereign wealth fund, and SII have also announced cooperation to produce the Russian Sputnik vaccine against coronavirus in India.The first batch of Sputnik vaccines is expected to be produced at SII's facilities in September, and both parties intend to produce over 300 million doses of the vaccine in India per year."As part of the technology transfer process, SII has already received cell and vector samples from the Gamaleya Center. With their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun," Dmitriev said in a statement issued by RDIF.India is the leading production hub for the Sputnik vaccine. RDIF had earlier reached agreements with a number of pharmaceutical companies in India (Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma, Virchow Biotech and Morepen) for the production of the Russian vaccine.To date, the Russian Sputnik V vaccine has been registered in 67 countries globally with a total population of over 3.5 billion people. The data obtained by regulators of a number of countries during the vaccination of the population -- including in Argentina, Serbia, Bahrain, Hungary, Mexico, San Marino, UAE and others -- demonstrate that Sputnik V is one of the safest and most effective vaccines against coronavirus."RDIF is delighted to cooperate with SII, the world's largest vaccine manufacturer. This strategic partnership is a major step to substantially increase our production capabilities demonstrating a perfect example of joining forces and expertise to save lives both in India and around the world. With technology transfer underway we expect the first batches of the vaccine to be produced jointly with SII in coming months," Dmitriev added.Talking about the partnership, Adar Poonawalla, CEO of SII said with high efficacy and a good safety profile, it is critical that the Sputnik vaccine is accessible in full measure for people across India and the world."I am delighted to partner with RDIF to manufacture the Sputnik vaccine. We hope to make millions of doses in the coming months with trial batches starting in the month of September. With high efficacy and a good safety profile, it is critical that the Sputnik vaccine is accessible in full measure for people across India and the world. Given the uncertainty of the virus, it is important for international institutes, and governments to collaborate and further bolster up our fight against the pandemic," said Poonawalla.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Kirill DmitrievFOLLOW

Kirill dmitriev, Latest News

Argentina's Laboratorios Richmond has delivered the first batch of over 1 million doses of the Sputnik V vaccine produced in Argentina to the country's health ministry, the company said in a joint statement with the Russian Direct Investment Fund on ...

The Russian Direct Investment Fund on Wednesday announced that combination of the first component of Sputnik V vaccine with vaccines by AstraZeneca, Sinopharm, and Moderna demonstrated favorable results. ...

The Russian Direct Investment Fund on Wednesday announced that combination of the first component of Sputnik V vaccine with vaccines by AstraZeneca, Sinopharm, and Moderna demonstrated favorable results. ...

The Russian Direct Investment Fund (RDIF) on Wednesday announced the approval of the Sputnik V vaccine against coronavirus in the Republic of Chile. ...

The Russian Direct Investment Fund (RDIF), an investor in the Russian Sputnik V vaccine against coronavirus, and VABIOTECH, one of Vietnam's leading pharmaceutical companies, announced the production of a test batch of the Russian Sputnik V vaccine a ...

The Russian Direct Investment Fund (RDIF) on Thursday announced the approval of the Russian Sputnik V vaccine against coronavirus by the National Agency for Food and Drug Administration and Control of Nigeria (NAFDAC). ...

The single-dose Sputnik Light COVID-19 vaccine is expected to launch soon in India said Russian envoy Nikolay Kudashev on Wednesday. ...

Russian Direct Investment Fund (RDIF) is expecting to release the results of Sputnik V and Astrazeneca 'mix and match' vaccine by the end of July. ...